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Abstract
Phosphatidylinositol-4,5-bisphosphate, PI(4,5)P2, is a phospholipid which plays important roles in clathrin-mediated
endocytosis. To investigate the possible role of this lipid on viral entry, two viruses important for animal health were
selected: the enveloped vesicular stomatitis virus (VSV)2 which uses a well characterized clathrin mediated endocytic route
2 and two different variants of the non-enveloped foot-and-mouth disease virus (FMDV) with distinct receptor specificities.
The expression of a dominant negative dynamin, a PI(4,5)P2 effector protein, inhibited the internalization and infection of
VSV and both FMDV isolates. Depletion of PI(4,5)P2 from plasma membrane using ionomycin or an inducible system, and
inhibition of its de novo synthesis with 1-butanol revealed that VSV as well as FMDV C-S8c1, which uses integrins as
receptor, displayed a high dependence on PI(4,5)P2 for internalization. Expression of a kinase dead mutant (KD) of
phosphatidylinositol-4-phosphate-5-kinase Ia (PIP5K-Ia), an enzyme responsible for PI(4,5)P2 synthesis that regulates
clathrin-dependent endocytosis, also impaired entry and infection of VSV and FMDV C-S8c1. Interestingly FMDV MARLS
variant that uses receptors other than integrins for cell entry was less sensitive to PI(4,5)P2 depletion, and was not inhibited
by the expression of the KD PIP5K-Ia mutant suggesting the involvement of endocytic routes other than the clathrin-
mediated on its entry. These results highlight the role of PI(4,5)P2 and PIP5K-Ia on clathrin-mediated viral entry.
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Introduction
Phosphatidylinositols (PIs) and their phosphorylated derivatives
are low abundant lipids in cellular membranes (,10% of total
phospholipids) that have been revealed as key membrane
components, particularly for membrane traffic [1]. One of these
lipids, phosphatidyilinositol-4,5-bisphosphate (PI(4,5)P2), which is
mostly localized in the internal hemimembrane of the plasma
membrane, participates in regulation of a variety of cellular
processes such as generation of membrane curvature, fission of
endosomes, exocytosis, and binding to different effectors of
clathrin-dependent endocytosis as well as at actin regulator
proteins [1,2,3,4]. In this way, depletion of PI(4,5)P2 from plasma
membrane has been shown to inhibit clathrin-mediated endocy-
tosis [2,3,4,5,6,7]. In this endocytic route, clathrin-coated pits
(CCPs) are assembled at the plasma membrane from cytosolic coat
proteins. Upon capture of transmembrane receptor molecules
CCPs invaginate to maturate into clathrin-coated vesicles (CCVs)
[8]. Recent reports have shown that synthesis of PI(4,5)P2 is the
major determinant of PI(4,5)P2 availability for CCP initiation and
nucleation by contributing to progression beyond the endocytosis
checkpoint and stabilization of nascent CCPs [2,3,4,5,6,9,10].
Although late states of CCP maturation to CCV do not require the
synthesis of PI(4,5)P2, the presence of this lipid is necessary to bind
proteins involved in CCV scission [2,11]. As the other PIs,
PI(4,5)P2 carries out these regulatory functions by binding to
different effector proteins through well characterized domains [1].
It is suggested that PI(4,5)P2 levels regulate CCP assembly,
whereas localized turnovers of this phospholipid can control
multiple stages in CCV formation [2,12]. The major route for
PI(4,5)P2 synthesis is the phosphorylation of PI4P by type I
phosphatidylinositol-4-phosphate-5-kinase (PIP5K-I) [13]. Among
the three isoforms reported for this enzyme (a, b and c) [13],
PIP5K-Ia is the major isoform involved in the regulation of
clathrin-dependent endocytosis [2].
Proteins interacting with PIs (e.g Rab proteins, dynamin) have
been involved in the entry of multiple viruses
[14,15,16,17,18,19,20], thus pointing the importance of specific
PIs in several steps for viral progression. However, a direct
involvement of PIs, and specifically of PI(4,5)P2, in viral entry has
been poorly evaluated, and the evidence for this is limited to the
Human immunodeficiency virus type-1 (HIV-1) entry [21]. Indeed,
HIV-1 binding to the plasmamembrane through Env-gp120 actives
an specific isoform of PIP5K protein, increasing the production of
PI(4,5)P2. In addition, PI(4,5)P2 is required for late steps of HIV-1
and HIV-2 infection to promote the localization of Gag protein on
plasma membrane during viral assembly [22,23].
In the present study, we addressed the role of PI(4,5)P2 on the
internalization of non-enveloped as well as of enveloped viruses.
For this purpose, two important pathogens for animal health,
causing clinically indistinguishable diseases, were selected: foot-
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and-mouth disease virus (FMDV) and vesicular stomatitis virus
(VSV). FMDV is a small, non-enveloped virus responsible for
a highly contagious disease affecting cloven-hoofed animals [24].
FMDV initiates infection of cultured cells via different av integrins
[25,26,27,28], although receptors different from integrins can be
used by FMDV variants selected upon passages in cultured cells
[29,30]. FMDV isolates that recognize integrins as cellular
receptor utilize CCPs to enter cultured cells [31,32,33], while
FMDV variants using heparan sulphate (HS) proteoglycans as
receptor instead of integrins are internalized via caveolae [34]. To
compare the PI(4,5)P2 requirements derived from the use of
distinct cellular receptors, two different FMDV isolates were
included in the study: C-S8c1 that is dependent on integrins for
infection [35] and MARLS, a C-S8c1 derivative that has acquired
the ability to enter cultured cells using HS and other not well
characterized receptor(s) [29,36]. On the other hand, VSV is an
enveloped virus that has become a widely used system for the study
of the clathrin-mediated endocytosis of viruses [37,38,39,40].
Our results showed that dynamin 2 a PI(4,5)P2 effector 2 was
a common requirement for infection of VSV and the two FMDVs
analyzed. In contrast, while endocytosis of both FMDV C-S8c1
and VSV was highly dependent on plasma membrane PI(4,5)P2,
that of FMDV MARLS showed a lower dependence on this
phospholipid.
Results and Discussion
Functional Requirement of Dynamin for FMDV and VSV
Infection
PI(4,5)P2 is involved in several cellular events as a result of its
binding to different partners [1,4,41,42,43,44,45]. One of these
proteins is the GTPase dynamin that works in endocytosis as
a regulatory molecule and as a component of the fission machinery
[46]. This prompted us to analyze the effect of the expression of
a dominant negative (DN) form of dynamin (Dyn K44A) [47] on
the entry of two FMDV isolates with different receptor specificities
(C-S8c1 and MARLS). In this study, VSV was included as
a positive control since it is well documented that dynamin is
necessary for its entry [37,38,40]. BHK-21 cells were transfected
with the corresponding plasmid, incubated with the viruses, and
analysed by confocal microscopy as described [32,48]. In cells
expressing the WT dynamin, the viral particles were located inside
the cells. However, the virions were observed at the cellular
periphery in cells expressing the DN dynamin (Fig. 1A). When the
percentage of cells with internalized viral particles was estimated
by confocal microscopy,similar values were observed in control
cells infected with VSV, C-S8c1 and MARLS, while the
percentages were significantly reduced in cells expressing DN
dynamin (12%, 11% and 4%, respectively), indicating that all
viruses tested required dynamin for cell entry (Fig. 1B). In
addition, expression of DN dynamin significantly reduced the
percentage of transfected-infected cells for C-S8c1, MARLS and
VSV (Fig. 1C), and no significant differences between the degrees
of inhibition of the three viruses were noticed. Overall, these
results indicate the functional requirement of this PI(4,5)P2-
interacting protein for the entry and infection of the three viruses
tested.
Effect of Depletion of PI(4,5)P2 on FMDV and VSV
Internalization
It has been documented that ionomycin treatment reduces the
levels of PI(4,5)P2 by activation of phospholipase C [4]. BHK-21
cells were transfected with a reporter plasmid (PH-PLC-eGFP)
[49] that expresses a fusion protein that binds and allows detection
of this phospholipid by fluorescence microscopy [44]. Under
control conditions, fluorescence was concentrated at the plasma
membrane. However, in cells treated with 5 mM ionomycin as
described [4], a cytoplasmic distribution of the reporter for
PI(4,5)P2 was observed (Fig. 2A). This result confirmed that
ionomycin treatment induced a depletion of PI(4,5)P2 from plasma
membrane, which resulted in a cytoplasmic relocation of the
fluorescent reporter protein. The effect of this drug on clathrin-
mediated endocytosis was further analyzed by using fluorescent
transferrin (TF), a marker of clathrin-mediated endocytosis [50].
In contrast to non treated cells, those treated with ionomycin
displayed a reduction in TF internalization (Fig. 2B). As these
results supported the conclusion that ionomycin treatment affected
clathrin-mediated endocytosis, the effect of this drug on virus
internalization was tested. Thus, BHK-21 cells were treated with
ionomycin, incubated with the viruses and the proportion of cells
that internalized viral particles was determined by immunofluo-
rescence and confocal microscopy. As expected, ionomycin
treatment inhibited (reduction by 90%) the internalization of
VSV particles (Fig. 2C), whose entry through clathrin-mediated
endocytosis is well characterized [37,38,39,40], and a similar
reduction was observed for FMDV C-S8c1 that enters into the
cells via CCPs [32]. However, the inhibition was lower for FMDV
MARLS (only a reduction about 40%), which has the ability to use
cellular receptors other than integrins. These results highlight that
depletion of PI(4,5)P2 from plasma membrane inhibits endocytosis
of viruses that use CCV, and reveal that the different in-
ternalization pathway followed by C-S8c1 and MARLS FMDV
variants can modulate PI(4,5)P2 requirement. Ionomycin treat-
ment induced a significant reduction (close to 30%) on cell viability
(Fig. S1A). To rule out that the inhibitory effect of this drug on
viral entry could be related to major metabolic alterations, the
effect of modulation of PI(4,5)P2 was further assayed using drugs
with lower cytotoxicity.
Effect of Inhibition of PI(4,5)P2 Synthesis on FMDV and
VSV Internalization
Rather than causing PI(4,5)P2 depletion from plasma mem-
brane, as described for ionomycin, primary alcohols, like 1-
butanol, promote phospholipase D (PLD) to generate phospha-
tidylalcohols instead of phosphatidic acid (PA), leading to a lower
activation of PIP5Ks and consequently inhibiting PI(4,5)P2
synthesis and CCP assembly [5]. On the other hand, this effect
does not occur in the presence of secondary alcohols such as 2-
butanol [5]. Treatment with either 1.5% 1-butanol or 2-butanol
did not affect the distribution pattern observed for the PI(4,5)P2
reporter (Fig. 3A), confirming that none of these alcohols
produced a significant depletion of PI(4,5)P2 from plasma
membrane. However, treatment with 1-butanol reduced the
ability of BHK-21 cells to internalize TF, indicating a require-
ment for de novo synthesis of PI(4,5)P2 of clathrin-mediated
endocytosis (Fig. 3B). As expected, treatment with 2-butanol did
not result in reduction of TF internalization, confirming the
specificity of the inhibition of clathrin-mediated endocytosis by 1-
butanol. In contrast to ionomycin, treatment with either 1 or 2-
butanol did not significantly affect cell viability (Fig. S1B),
confirming that the reduction of clathrin-mediated endocytosis by
1-butanol was not related to major toxic effects of the drug.
Regarding viral entry, treatment with 1-butanol reduced by 90%
the internalization of C-S8c1 and VSV. Conversely, it only
reduced MARLS internalization by 50%, suggesting that the
different receptor used by MARLS and C-S8c1 for cell entry can
modulate the requirement of PI(4,5)P2 synthesis. The specificity
of this inhibition was confirmed as treatment with 2-butanol
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resulted in a limited reduction by 10% in the internalization of
each of the three viruses analyzed (Fig. 3C). These results
indicate that FMDV and VSV require synthesis of PI(4,5)P2 at
the plasma membrane for internalization, and again suggest
differences between MARLS and C-S8c1 internalization path-
ways.
Effect of Induced Depletion of PI(4,5)P2 from the Plasma
Membrane on FMDV and VSV Internalization
To confirm the results obtained with pharmacological inhibi-
tors, the effect of PI(4,5)P2- targeted depletion with an inducible
system [45] was analyzed. The approach used, which has been
proven to be highly specific [4,51,52], is based on the conditional
recruitment to plasma membrane of an inositol 5-phosphatase –
fused to red fluorescent protein (RFP)– by its rapamycin-induced
heterodimerization with a membrane-targeted, rapamycin-bind-
ing domain of mTOR fused to the cyan fluorescent protein (CFP)
[45]. In this way, only when rapamycin is added to the culture
medium, both fusion proteins interact and the phosphatase is
recruited to plasma membrane causing a targeted depletion of
PI(4,5)P2. First, we evaluated that this system induced the
depletion of PI(4,5)P2 from the plasma membrane when
rapamycin was added to BHK-21 cells (Fig. 4). To this end, cells
were cotransfected for 24 h with plasmids encoding phosphatase
(mRFP-FKBP-dom5ptase), membrane anchored rapamycin-bind-
ing domain (PM-FRB-CFP) and PH-PLC-eGFP (to detect
PI(4,5)P2). Then, cells were treated with rapamycin for 10 min
to induce the depletion of PI(4,5)P2 from plasma membrane. As
expected, when rapamycin was added the fluorescence of PI(4,5)P2
reporter protein was relocated from plasma membrane to the
cytoplasm (Fig. 4). Next, cells cotransfected with plasmids mRFP-
FKBP-dom5ptase and PM-FRB-CFP, were treated with rapamy-
cin to induce the PI(4,5)P2 depletion, and then incubated with the
viruses (Fig. S2). About 89% of the cells expressing both plasmids
in the absence of rapamycin were able to internalize C-S8c1
(Table 1). However, when rapamycin was added, only 12% of
cotransfected cells were shown to internalize C-S8c1 particles.
Addition of rapamycin similarly reduced the number of cells
internalizing VSV (from 88% in control cells to 15% in
rapamycin-treated cells for VSV). On the other hand, targeted
depletion of PI(4,5)P2 only slightly reduced the percentage of cells
internalizing MARLS (from 83% in control cells to 76% in
rapamycin treated cells) (Table 1). Rapamycin alone had no effect
on viral internalization of any of the three virus tested, since
treatment with rapamycin of untransfected cells or cells only
transfected with one plasmid did not reduce the percentages of
cells that internalized the viral particles (data not shown). Overall,
these results support those previously obtained with pharmaco-
logical treatments, indicating that internalization of FMDV C-
S8c1 and VSV strongly depends on plasma membrane PI(4,5)P2
phospholipids, while MARLS internalization is less sensitive to
PI(4,5)P2 depletion. These differences could be explained by the
Figure 1. Functional requirement for dynamin of FMDV and VSV infection. (A) BHK-21 cells transfected with eGFP fused to WT or a DN
version of dynamin (eGFP-Dyn WT and eGFP-Dyn K44A, respectively) and 24 h later were incubated with the different FMDV variants (C-S8c1 and
MARLS) or VSV (MOI of 70 PFU/cell) for 25 min and processed for immunofluorescence. Nuclei were stained using ToPro-3 (blue). GFP and viruses are
shown in green and red, respectively. Bar: 10 mm. (B) BHK-21 cells transfected and infected as in (A). The graph represents the percentage of cells that
showed internalized virus, determined as described in Materials and Methods. At least 100 transfected cells per coverslip were scored in each assay (3
coverslip). (C) BHK-21 cells were electroporated with a plasmid encoding eGFP-Dyn WT as control, or eGFP-Dyn K44A. At 24 h post-electroporation,
monolayers were infected with the corresponding virus (MOI of 1 PFU/cell). Cells were fixed and processed for immunofluorescence at 7 h post-
infection. Bars represent the mean percentage of transfected and infected cells 6 SD, normalized to the level of infection of cells expressing the
eGFP-Dyn WT. Statistically significant differences between cells transfected with eGFP-Dyn WT or K44A are indicated by an asterisk (ANOVA P#0.05).
doi:10.1371/journal.pone.0045172.g001
Figure 2. Effect of PI(4,5)P2 depletion by ionomycin on FMDV and VSV internalization. (A) Visualization of PI(4,5)P2 depletion from plasma
membrane. BHK-21 cells transfected (24 h) with PH-PLC-eGFP, encoding a reporter protein for PI(4,5)P2 fused to GFP (green), were treated or not with
5 mM ionomycin 30 min and then fixed and observed by confocal microscopy. Nuclei were stained using ToPro-3 (blue). Bar 10 mm. (B) Treatment
with ionomycin inhibits clathrin-mediated endocytosis. BHK-21 cells, treated with ionomycin as in (A), were incubated with Alexa Fluor 488-labelled
TF (green) for 5 min in the presence of the drug and extracellular TF was eliminated by acid wash as described [32]. Cells were fixed and nuclei were
stained using DAPI (blue). Bar: 10 mm. (C) Inhibition of the ability of cells to internalize FMDV and VSV upon ionomycin treatment. Cells treated with
ionomycin as in (A) were incubated with the different FMDV variants (C-S8c1 and MARLS) or with VSV (MOI of 70 PFU/cell) for 25 min in the presence
of ionomycin. Cells were fixed and processed for immunofluorescence to stain viral particles as described in Materials and Methods. Bars represent
the mean percentage of cells with internalized virions 6 SD, normalized to the level of cells with internalized virions in control samples. At least 500
cells per coverslip were scored for each case (3 coverslips). Asterisks denote statistically significant differences (ANOVA P#0.05).
doi:10.1371/journal.pone.0045172.g002
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usage of an alternative dynamin-dependent endocytic pathway,
such as caveolae, for MARLS internalization, since caveolae-
mediated endocytosis can rely on dynamin function [53] and is less
sensitive to PI(4,5)P2 depletion than clathrin-mediated endocytosis
[54]. In fact, as commented in the introduction, MARLS could
utilize HS binding to gain entry into cells through caveolae.
PIP5K-Ia is Required for Efficient FMDV C-S8c1 and VSV
Entry and Infection
Three distinct isoforms of PIP5K-I (a, b, and c) are responsible
for the synthesis of a major proportion of PI(4,5)P2 in the cell,
through the hosphorylation of PI4P [13]. Among these enzymes,
Figure 3. Effect of blocking de novo synthesis of PI(4,5)P2 with 1-butanol on FMDV and VSV internalization. (A) BHK-21 cells transfected
(24 h) with PH-PLC-eGFP (green) were treated or not with 1.5% 1-butanol or 2-butanol for 5 min and then fixed and observed by confocal
microscopy. Nuclei were stained using ToPro-3 (blue). Bar 10 mm. (B) Treatment with 1-butanol inhibits clathrin-dependent endocytosis. BHK-21 cells
were treated as in (A) were incubated with fluorescent TF and processed as described in the legend of Fig. 1. Bar: 10 mm. (C) Reduction of the ability
of cells to internalize FMDV and VSV upon 1-butanol treatment. Cells treated as in (A) were incubated with the different FMDV variants (C-S8c1 and
MARLS) or VSV (MOI of 70 PFU/cell) for 25 min in the presence of the drugs. Bars represent the mean percentage of cells with internalized virions 6
SD, normalized to the level of cells with internalized virions in control samples. At least 500 cells per coverslip were scored for each case (3 coverslips).
Asterisks denote statistically significant differences (ANOVA P#0.05).
doi:10.1371/journal.pone.0045172.g003
PI(4,5)P2 in FMDV and VSV Entry
PLOS ONE | www.plosone.org 5 September 2012 | Volume 7 | Issue 9 | e45172
PI4P5K-Ia has been identified as the main isoform that regulates
clathrin-dependent endocytosis [2,55]., and expression of kinase
dead (KD) or truncated mutants of PIP5K-Ia impairs clathrin
mediated endocytosis [55]. In this regard, the role of this kinase on
the internalization of FMDV (C-S8c1 and MARLS) and VSV was
addressed by studying the effect of the expression of a KD mutant
of PIP5K-Ia fused to mCherry protein – mCherry-PIP5KIa
D268A [2] – on the entry and infection of these viruses. BHK-21
cells were transfected, incubated with the viruses, processed and
analyzed by confocal microscopy as described [32,48]. The
percentages of cells expressing KD PIP5K-Ia that internalized
VSV or C-S8c1 were significantly lower than those of control cells,
being the reduction values of 66% and 55%, respectively (Fig. 5A).
On the other hand, expression of KD PIP5K-Ia did not reduce the
percentage of MARLS viral particles internalized by cells when
compared with control samples (Fig. 5A). In addition to this,
Figure 4. Depletion of PI(4,5)P2 from plasma membrane after rapamycin-induced membrane targeting of an inositol 5-
phosphatase. BHK-21 cells were cotransfected with PM-FRB-CFP (blue), mRFP-FKBP-dom5ptase (red) and PH-PLC-eGFP (green) plasmids using
Lipofectamine Plus. At 24 h post-transfection, cells were treated with 10 nM rapamycin (10 min) to induce the depletion of PI(4,5)P2 from plasma
membrane. Then cells were fixed and observed by confocal microscopy. A representative example of a co-transfected cell is shown. See text for
details regarding the inducible system for PI(4,5)P2 depletion. Differential interference contrast (DIC) images are also shown. Bar: 10 mm.
doi:10.1371/journal.pone.0045172.g004
Table 1. Inducible depletion of PI(4,5)P2 from plasma membrane inhibits internalization of FMDV and VSV.
% Cells with internalized
virions
% Cells without internalized
virions P-value
CS8-c1 Control 89 11 0.0001*
Rapamycin 12 88
MARLS Control 83 17 0.2202
Rapamycin 76 24
VSV Control 88 12 0.0001*
Rapamycin 15 85
Number of cotransfected cells scored: 100.
*Statistically significant difference.
doi:10.1371/journal.pone.0045172.t001
PI(4,5)P2 in FMDV and VSV Entry
PLOS ONE | www.plosone.org 6 September 2012 | Volume 7 | Issue 9 | e45172
expression of KD PIP5K-Ia significantly reduced the percentage
of transfected-infected cells for C-S8c1 (83% reduction) and VSV
(53% reduction) (Fig. 5B). Conversely, in the case of MARLS an
increase in the percentage of transfected-infected cells was
observed upon expression of KD PIP5K-Ia. These results indicate
the functional requirement of the PIP5K-Ia for the entry and
infection of C-S8c1 and VSV, but not for MARLS. Even when
further work is required to understand the infection increase
caused by KD PIP5K-Ia on MARLS infection, these differences
support the notion that MARLS is internalized using of an
alternative dynamin-dependent non-clathrin endocytic pathway
less affected by modulation of plasma membrane PI(4,5)P2 and
independent on PI4P5K-Ia function.
Considering these results, modulation of PI(4,5)P2 metabolism,
and of PIP5K function (especially PIP5K-Ia) could potentially
constitute a new antiviral approach to fight viral diseases, a concept
Figure 5. PIP5K-Ia is involved on entry and infection of FMDV C-S8c1 and VSV. (A) BHK-21 cells transfected with mCherry fused to WT or
a KD version of PIP5K-Ia (mCherry-PIP5K-Ia WT and mCherry-PIP5K-Ia D268A, respectively) and 24 h later were incubated with the different FMDV
variants (C-S8c1 and MARLS) or VSV (MOI of 70 PFU/cell) for 25 min and processed for immunofluorescence. The graph represents the percentage of
cells that showed internalized virus determined as described in Materials and Methods. At least 100 transfected cells per coverslip were scored for
each assay (3 coverslip). (B) BHK-21 cells were electroporated with a plasmid encoding mCherry-PIP5K-Ia WT as control, or mCherry-PIP5K-Ia D268A.
At 24 h post-electroporation, monolayers were infected with the corresponding virus (MOI of 1 PFU/cell) and cells were fixed and processed for
immunofluorescence at 7 h post-infection. Bars represent the mean percentage of transfected and infected cells 6 SD, normalized to the level of
infection of cells expressing the mCherry-PIP5K-Ia WT. Statistically significant differences between cells transfected with mCherry-PIP5K-Ia WT or
D268A are indicated by an asterisk (ANOVA P#0.05).
doi:10.1371/journal.pone.0045172.g005
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which has been already proposed for HIV-1 [21]. However, acute
depletion of this lipid from plasma membrane has different effects
on cellular functions [45], thus constituting a major concern for its
potential application in vivo. Nevertheless, the experience with
a variety of PI kinases that regulate synthesis of different PI species
has revealed that these enzymes, and the lipids they synthesize,
constitute good druggable targets to treat diverse diseases [56],
including viral infections [57,58,59,60], cancer [61,62] or diabetes
[63]. In particular, specific isoforms of PI 4-kinases can be
chemically inhibited resulting in a blockage of viral replication
without having a significant impact on cell viability [64]. As
PI(4,5)P2 requirement is expected to be shared by a wide variety of
viruses that are internalized using clathrin-mediated endocytosis,
successful intervention on this pathway could lead to the
development of broad spectrum antivirals. This concept, already
proposed for PI 4-kinases, could offer therapeutic advantages since
inhibition of host components instead of viral components could
circumvent the problem of rapid selection of drug-resistant viruses
– for a discussion see [64] –. Indeed, modulation of the metabolism
of specific lipids is currently raising as a feasible antiviral approach
[65,66,67]. Overall, the results presented in this study highlight the
involvement of PI(4,5)P2, on viral entry of either enveloped and
non-enveloped viruses. Further work has to be performed to
evaluate the feasibility of the depletion of PI(4,5)P2 from plasma
membrane as a novel antiviral strategy.
Materials and Methods
Cells and Viruses
BHK-21 cells (ATCC) were grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 5% fetal calf serum
(FCS), L-glutamine (2 mM), penicillin (100 U/ml), and strepto-
mycin (100 mg/ml). FMDV isolate C-S8c1 is a derivative of a type
C field virus isolated in Santa Pau (Spain, 1970) by triple plaque
purification [68]. MARLS virus is a monoclonal antibody (MAb)-
resistant mutant isolated with MAb SD6, which recognizes the G-
H loop of capsid protein VP1 [69], from C-S8c1 virus after 213
passages on BHK-21 cells [36]. Mutations in MARLS virus
compared to parental C-S8c1 have described previously [29].
VSV Indiana [70] was also used. The sequence of the capsid
proteins of C-S8c1 and MARLS stocks used in this work was
confirmed by RT-PCR amplification of viral RNA and sequencing
of the amplicons obtained as described [71].
Antibodies and Reagents
FMDV VP1 and VSV glycoprotein (G) protein were detected
using MAb 5C4 [72] and I1 [73], respectively. Goat anti-mouse
IgG labelled with Alexa Fluor (AF) 555 or 647 were from
Molecular Probes. Transferrin (TF) conjugated to AF 488 was
from Invitrogen. Ionomycin (Sigma) and rapamicyn (Calbiochem)
were prepared in DMSO as 1.4 mM and 1.1 mM stock solutions,
respectively. 1-butanol and 2-butanol were from Merck.
Drug Treatments
BHK-21 cells grown on coverslips were washed twice with
DMEM and incubated with ionomycin (5 mM) for 30 min, or with
1.5% 1-butanol or 2-butanol for 5 min. Control cells were
incubated in the same conditions in DMEM containing the
solvent concentration used for each drug. The drug was
maintained during the virus internalization time. Cell viability
upon drug treatments was determined by propidium iodide
staining and flow cytometry [74,75] using a FACScalibur flow
cytometer (Becton Dickinson).
Plasmids and Transfections
The following plasmids were used in this study: eGFP-Dyn WT
eGFP-Dyn K44A [47], PH-PLC-eGFP [44], PM-FRB-CFP,
mRFP-FKBP-dom5ptase [45], mCherry-PIP5K-Ia WT and KD
mCherry-PIP5K-Ia D268A [2] (all the PIP5K isoform designa-
tions in the text refer to the human nomenclature for these genes).
BHK-21 cells were transfected using Lipofectamine Plus (Invitro-
gen) as described by the manufacturer or electroparated with the
corresponding plasmid using Gene Pulser XCellTM (Bio Rad).
Immunofluorescence
Immunofluorescence was performed as described previously
[76]. For confocal microscopy; a LSM510 META Inverted (Zeiss)
confocal laser scanning microscope coupled to an Axiovert200
(Zeiss) inverted microscope (objective Plan-Apochromat 63x/AN
1.4) was used. Images were acquired using Zeiss LSM510 4.2 Sp2
software. The percentage of cells which internalized viral particles
was determined by observation of Z-stacks (scan zoom 16, step
size 0.4 mm) (n $100) of cells using confocal microscopy [77]. For
conventional fluorescence microscopy an Axioskop (Zeiss) fluores-
cence microscope coupled to a Coolsnap FX monochrome camera
Roper Scientific was used and were acquired using RS Image
software (Roper Scientific). To determine the number of infected
cells, more than 150 cells expressing GFP were analyzed and the
experiment was carried out three independent times. The images
were processed using Adobe Photoshop 7.0 (Adobe System Inc.).
Data Analysis
Analysis of variance (ANOVA) using F Fischer-Snedecor
distribution was performed with statistical package SPSS v.17.0
(SPSS Inc) for Windows. Data are presented as means 6 standard
deviations (SD). Chi-square test was performed with statistical
package Graph Pad Prism. Statistically significant differences are
denoted in the figures by one asterisk for a P value of ,0.05.
Supporting Information
Figure S1 Analysis of cellular viability upon drug
treatments. Cellular viability upon treatment with ionomycin
(A) or 1 and 2-butanol (B) was determined by propidium iodide
staining and flow cytometry. Control cells were treated in parallel
with drug vehicles.
(TIF)
Figure S2 Inducible depletion of PI(4,5)P2 from plasma
membrane inhibits internalization of FMDV and VSV.
BHK-21 cells were cotransfected with PM-FRB-CFP – indicated
as CFP (blue) – and mRFP-FKBP-dom5ptase – indicated as RFP
(red) – plasmids [45]. At 24 h post-transfection, cells were treated
(right panels) or not (left panels) with 10 nM rapamycin (10 min)
to induce the depletion of PI(4,5)P2 from plasma membrane.
Then, cells were incubated with the different viruses (green) (MOI
of 70 PFU/cell, 25 min) in the presence of rapamycin and cells
were processed for immunofluorescence. The percentage of cells
that showed internalized virions, determined as described in
Materials and Methods, is indicated. White dashed lines indicate
the cell periphery of cotransfected cells; white solid lines indicate
the cell periphery of untransfected cells. Insets show the lasser lines
corresponding to the fluorochromes expressed by each of the
transfecting plasmids, as well as a DIC image depicting the shape
of the cells present in each field. Bar: 10 mm.
(TIF)
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